Emerging therapies in management of AMD

Video

Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

Anat Loewenstein, MD, chair, Department of Ophthalmology, Tel Aviv Medical Center (Israel), provides an update on the latest developments in emerging therapies for the management of age-related macular d

Recent Videos
Related Content
Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint

Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint

Martin David Harp
March 25th 2025
Article
John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice

Implementing Higher Molar Dose in Your Clinical Practice

John Kitchens, MD;Peter K. Kaiser, MD
July 24th 2024
Podcast
The future of retina: New targets and more durable solutions

The future of retina: New targets and more durable solutions

Robin Vora, MD;Hannah El-Sabrout
March 18th 2025
Article
4DMT enrolls first patient in phase 3 4FRONT-1 evaluating 4D-150 for the treatment of wet AMD

4DMT enrolls first patient in phase 3 4FRONT-1 evaluating 4D-150 for the treatment of wet AMD

Martin David Harp
March 11th 2025
Article
Data from Phase 1/2a clinical trial evaluating RPESC-RPE-4W presented at 77th Annual Wills Eye Conference

Data from Phase 1/2a clinical trial evaluating RPESC-RPE-4W presented at 77th Annual Wills Eye Conference

Sydney M Crago
March 8th 2025
Article
PER launches Retina Resource, a comprehensive anti-VEGF education and information tool

PER launches Retina Resource, a comprehensive anti-VEGF education and information tool

Sydney M Crago
March 7th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.